This symposium also covers the effectiveness of antihistamines, the search for a non-sedating antihistamine and allergic rhinitis.
Professor Triggiani starts his presentation by discussing various recent developments in the action of histamine and its receptors. He presents bilastine and its pre-clinical data and early clinical profiles, which highlight its selectivity and safety for the receptor.
